[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.167.142.229. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Observation
January 2016

A Case of Rapid Eye Movement Sleep Behavior Disorder in Parkinson Disease Treated With Sodium Oxybate

Author Affiliations
  • 1Stanford Sleep Medicine Center, Redwood City, California
  • 2UBC Health Sciences Center Hospital, Vancouver, British Columbia, Canada
JAMA Neurol. 2016;73(1):126-127. doi:10.1001/jamaneurol.2015.2904

Rapid eye movement (REM) sleep behavior disorder (RBD) is characterized by altered dream mentation, vocalizations, and dream enactment behavior (DEB). The motor behavior is often aggressive, resulting in potential injury to the patient or bed partner. Clonazepam and melatonin are considered standard treatments. Limited data exist on the use of alternative agents when standard medications fail. We report a case of successfully treated RBD in advanced Parkinson disease (PD) with sodium oxybate in a patient refractory to both standard and alternative pharmacologic agents.

First Page Preview View Large
First page PDF preview
First page PDF preview
×